Cardiovascular DiseasesNCT00005707
Improving Hypertension Care for Inner City Minorities
An observational study of Cardiovascular Diseases and Heart Diseases, run by Baylor College of Medicine.
Trial summary
To improve long-term blood pressure BP) control in a predominantly African-American, low SES community of a large city. Read more about this study
- Who is it for?
- Ages Up to 100 years, men only
- Conditions the study is for
- Cardiovascular Diseases, Heart Diseases, Hypertension
- How many people
- Not given
- Where
- No sites listed yet
- Study dates
- Sep 1993to Aug 1998
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 100 years
- Men only
- No healthy volunteers
- Child, Adult, Older adult
No eligibility criteria
About this study
To improve long-term blood pressure BP) control in a predominantly African-American, low SES community of a large city.
Read the detailed description
BACKGROUND:
The study was in response to a demonstration and education initiative, "Improving Hypertensive Care for Inner City Minorities", which was reviewed and approved by the Clinical Applications and Prevention Advisory Committee in April 1992 and by the National Heart, Lung, and Blood Advisory Council in May 1992. The Request for Applications was released in October 1992.
DESIGN NARRATIVE:
Components of the program included a community education campaign, an educational intervention for private physicians, and major modifications in the process of care for hypertensives in a health care system that was the largest single provider to the target area. The intervention area was compared to a similar community in another part of the city which was served by different private and public providers. Pre- and post-intervention random samples of persons ages 18-74 were selected from each geographical area to assess the effectiveness of the program in reducing the prevalence of uncontrolled hypertension. The community intervention focused on improving awareness and need to maintain treatment. The private physician intervention focused on strategies for promoting long-term patient adherence. The public hospital clinic/systems components were: 1) educating providers, 2) instituting an evening clinic for the working poor, 3) providing tailored patient education programs which were culturally sensitive and did not require class attendance, and 4) implementing a program in the public hospital emergency center to identify and refer patients with undetected hypertension or hypertension not under regular care.
Efforts, including reminders and follow-up by community health center social workers, were used to keep patients active in treatment programs. The community intervention was directed by the co-investigator from Texas Southern University (TSU), an historically Black university located in the intervention area. He had extensive experience in community outreach. The intervention toward private physicians was directed by investigators from Baylor College of Medicine who had established clinical credibility in the physician community. The investigators from Baylor also had direct supervision over the physicians who provided care in the Harris County Hospital District (HCHD) public health care system. The HCHD was deeply committed to the project and had a high level of representation in all the planning phases.
- Conditions
- Cardiovascular Diseases, Heart Diseases, Hypertension
- Medical subject headings
- Cardiovascular Diseases, Heart Diseases, Hypertension
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 May 2000 (estimated)
- Study startSep 1993
- Study completionAug 1998
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Cardiovascular DiseasesStudies of the same condition, open and under way.
- More trials run by Baylor College of MedicineThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
Sponsor and investigators
- Lead sponsor
- Baylor College of Medicine
- Sponsor type
- University, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00005707
- Sponsor's protocol ID
- 4916
- Other IDs
- R01HL051121
- Status last verified
- Dec 2015
- First submitted
- 25 May 2000
- Last updated
- 10 Dec 2015
- Results posted
- No
Publications
Hyman DJ, Pavlik VN, Vallbona C, Dunn JK, Louis K, Dewey CM, Wieck L. Blood pressure measurement and antihypertensive treatment in a low-income African-American population. Am J Public Health. 1998 Feb;88(2):292-4. doi: 10.2105/ajph.88.2.292.
PubMed 9491026Wieck KL. Hypertension in an inner-city minority population. J Cardiovasc Nurs. 1997 Jul;11(4):41-9. doi: 10.1097/00005082-199707000-00005.
PubMed 9200018
Study at a glance
From the registry record, last updated by the sponsor on 10 Dec 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Improving Hypertension Care for Inner City Minorities
- ClinicalTrials.gov ID
- NCT00005707
- Acronym / sponsor ID
- 4916
- Conditions
- Cardiovascular Diseases, Heart Diseases, Hypertension
- Study type
- Observational
- Recruitment status
- Completed
- Lead sponsor
- Baylor College of MedicineUniversity, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- Study start
- Sep 1993
- Study completion
- Aug 1998
- First posted
- 26 May 2000 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To improve long-term blood pressure BP) control in a predominantly African-American, low SES community of a large city.
Detailed description
BACKGROUND:
The study was in response to a demonstration and education initiative, "Improving Hypertensive Care for Inner City Minorities", which was reviewed and approved by the Clinical Applications and Prevention Advisory Committee in April 1992 and by the National Heart, Lung, and Blood Advisory Council in May 1992. The Request for Applications was released in October 1992.
DESIGN NARRATIVE:
Components of the program included a community education campaign, an educational intervention for private physicians, and major modifications in the process of care for hypertensives in a health care system that was the largest single provider to the target area. The intervention area was compared to a similar community in another part of the city which was served by different private and public providers. Pre- and post-intervention random samples of persons ages 18-74 were selected from each geographical area to assess the effectiveness of the program in reducing the prevalence of uncontrolled hypertension. The community intervention focused on improving awareness and need to maintain treatment. The private physician intervention focused on strategies for promoting long-term patient adherence. The public hospital clinic/systems components were: 1) educating providers, 2) instituting an evening clinic for the working poor, 3) providing tailored patient education programs which were culturally sensitive and did not require class attendance, and 4) implementing a program in the public hospital emergency center to identify and refer patients with undetected hypertension or hypertension not under regular care.
Efforts, including reminders and follow-up by community health center social workers, were used to keep patients active in treatment programs. The community intervention was directed by the co-investigator from Texas Southern University (TSU), an historically Black university located in the intervention area. He had extensive experience in community outreach. The intervention toward private physicians was directed by investigators from Baylor College of Medicine who had established clinical credibility in the physician community. The investigators from Baylor also had direct supervision over the physicians who provided care in the Harris County Hospital District (HCHD) public health care system. The HCHD was deeply committed to the project and had a high level of representation in all the planning phases.
Study design
Who may qualify
- Ages
- Up to 100 years
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Dec 2015.
- Background: PubMed 9491026Hyman DJ, Pavlik VN, Vallbona C, Dunn JK, Louis K, Dewey CM, Wieck L. Blood pressure measurement and antihypertensive treatment in a low-income African-American population. Am J Public Health. 1998 Feb;88(2):292-4. doi: 10.2105/ajph.88.2.292.
- Background: PubMed 9200018Wieck KL. Hypertension in an inner-city minority population. J Cardiovasc Nurs. 1997 Jul;11(4):41-9. doi: 10.1097/00005082-199707000-00005.
Related trials for Cardiovascular Diseases
Active, not recruitingPhase 3
ENDOTHELION Study Group: Effect of Bosentan in NAION Patients
Ischemic Optic Neuropathy
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Not yet recruitingPhase 2
Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma (RRMM)
RecruitingPhase 2
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
Multiple Myeloma
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Cardiovascular Diseases and Heart Diseases, run by Baylor College of Medicine.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Dec 2015. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00005707, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Dec 2015.